PUBLICATION

PAK4 suppresses PDZ-RhoGEF activity to drive invadopodia maturation in melanoma cells

Authors
Nicholas, N.S., Pipili, A., Lesjak, M.S., Ameer-Beg, S.M., Geh, J.L., Healy, C., MacKenzie Ross, A.D., Parsons, M., Nestle, F.O., Lacy, K.E., Wells, C.M.
ID
ZDB-PUB-180224-7
Date
2016
Source
Oncotarget   7: 70881-70897 (Journal)
Registered Authors
Keywords
PAK, PDZ-RhoGEF, RhoA, invadopodia, melanoma
MeSH Terms
  • Actins
  • Animals
  • Cell Line, Tumor
  • Fluorescent Antibody Technique
  • HEK293 Cells
  • Humans
  • Melanoma/pathology*
  • Neoplasm Invasiveness/pathology
  • Podosomes/pathology*
  • Protein Isoforms/metabolism
  • RNA Interference
  • RNA, Small Interfering/metabolism
  • Rho Guanine Nucleotide Exchange Factors/metabolism*
  • Signal Transduction
  • Skin Neoplasms/pathology*
  • Zebrafish
  • p21-Activated Kinases/genetics
  • p21-Activated Kinases/metabolism*
PubMed
27765920 Full text @ Oncotarget
Abstract
Cancer cells are thought to use actin rich invadopodia to facilitate matrix degradation. Formation and maturation of invadopodia requires the co-ordained activity of Rho-GTPases, however the molecular mechanisms that underlie the invadopodia lifecycle are not fully elucidated. Previous work has suggested a formation and disassembly role for Rho family effector p-21 activated kinase 1 (PAK1) however, related family member PAK4 has not been explored. Systematic analysis of isoform specific depletion using in vitro and in vivo invasion assays revealed there are differential invadopodia-associated functions. We consolidated a role for PAK1 in the invadopodia formation phase and identified PAK4 as a novel invadopodia protein that is required for successful maturation. Furthermore, we find that PAK4 (but not PAK1) mediates invadopodia maturation likely via inhibition of PDZ-RhoGEF. Our work points to an essential role for both PAKs during melanoma invasion but provides a significant advance in our understanding of differential PAK function.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping